Used as a protected amine intermediate (Boc-carbamate) in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its pyridine-based structure with a difluoromethyl substituent supports selective binding to enzyme targets in final drugs, enhancing efficacy and metabolic stability. Commonly employed in medicinal chemistry to improve pharmacokinetic properties such as bioavailability. Also utilized in agrochemical research for designing novel active ingredients with improved environmental profiles.